为炎症性肠病制定和验证健康饮食决策能力尺度:一个仪器设计研究
Yiting Li1, Yongqi Liang2, Murong Wang1
1College of Nursing, Nanjing University of Chinese Medicine, Nanjing, 210023, China.
BMC gastroenterology
|December 16, 2025
概括
一个新的尺度,健康饮食决策能力尺度 (HDMCS),被开发用于评估炎症肠病 (IBD) 患者的饮食决策能力. 这种经过验证的工具有助于医疗保健专业人员为更好的IBD管理量身定制饮食支持.
科学领域:
- 胃肠病学 胃肠病学
- 健康心理学 心理健康心理学
- 临床评估 临床评估
背景情况:
- 饮食管理对于炎症性肠病 (IBD) 患者至关重要,但也带来了挑战.
- 评估患者在做出健康饮食决策方面的能力对于有效的支持至关重要.
- 目前还没有有效的仪器来测量IBD的健康饮食决策能力.
研究的目的:
- 开发和验证一种工具,以评估IBD患者的健康饮食决策能力.
- 为医疗保健专业人员提供一个工具,以评估患者管理饮食的能力.
- 为了促进针对IBD管理的食干预措施的设计.
主要方法:
- 仪器开发涉及文献评论,与患者和专家的采访,以及认知采访.
- 规模验证包括在中国五家医院调查354名IBD患者.
- 进行了诸如项目分析,探索性和确认性因子分析以及可靠性测试等统计分析.
主要成果:
- 健康饮食决策能力尺度 (HDMCS) 是根据以下四个因素开发的:"饮食管理感知"",资源利用能力"",决策平衡能力"和"决策后反思能力".
- 因子分析证实了尺度的结构 (χ2/df=1.972,RMSEA=0.068,GFI=0.848,IFI=0.929,CFI=0.928). 这就是为什么我们使用这个方法.
- 该尺度表现出高可靠性 (克朗巴赫α=0.941) 和可接受的测试复试可靠性 (ICC=0.874).
结论:
- HDMCS是衡量IBD患者饮食决策能力的可靠和有效工具.
- 这种尺度使医疗保健专业人员能够全面了解患者的饮食决策领域.
- 研究结果支持根据患者个体能力量身定制干预措施,以改善IBD饮食管理.
相关概念视频
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
614
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
614
01:29Assessment of the Gastrointestinal System II: Health Perception Pattern
432
Assessing the gastrointestinal (GI) system is a complex process that begins with collecting subjective data. This data, collected through patient interviews, provides crucial insights into the patient's health history, perception patterns, and lifestyle habits, all contributing significantly to GI health.
Health Perception Patterns
Health perception patterns offer valuable insights into a patient's lifestyle habits and how they may impact their GI health. These patterns include:
Health Perception Patterns
Health perception patterns offer valuable insights into a patient's lifestyle habits and how they may impact their GI health. These patterns include:
432
01:30Inflammatory Bowel Disease II: Crohn's Disease
915
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
915
01:29Inflammatory Bowel Disease IV: Pharmacological Management
445
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
445
01:30Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
708
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
708
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
859
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
859